Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Distal Bile Duct Adenocarcinoma”

30 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 30 results

Testing effectiveness (Phase 2)Study completedNCT02042443
What this trial is testing

Trametinib or Combination Chemotherapy in Treating Patients With Refractory or Advanced Biliary or Gallbladder Cancer or That Cannot Be Removed by Surgery

Who this might be right for
Adult CholangiocarcinomaAdvanced Adult Hepatocellular CarcinomaBCLC Stage C Adult Hepatocellular Carcinoma+16 more
National Cancer Institute (NCI) 53
Not applicableEnded earlyNCT04561453
What this trial is testing

Feasibility Study of Multi-Platform Profiling of Resected Biliary Tract Cancer

Who this might be right for
Biliary Tract CancerCholangiocarcinomaGallbladder Cancer+5 more
University of Washington 14
Not applicableLooking for participantsNCT06801899
What this trial is testing

ToPanc Trial: Survival After Total Versus Partial Pancreaticoduodenectomy for Adenocarcinoma of the Pancreatic Head, Distal Cholangiocarcinoma, and Ampullary Cancer

Who this might be right for
Pancreatic Cancer
Insel Gruppe AG, University Hospital Bern 170
Not applicableStudy completedNCT05478889
What this trial is testing

Minimally Invasive Pancreatoduodenectomy for Distal Cholangiocarcinoma

Who this might be right for
Distal Cholangiocarcinoma
Fondazione Poliambulanza Istituto Ospedaliero 478
Early research (Phase 1)Active Not RecruitingNCT04491942
What this trial is testing

Testing the Addition of an Anti-cancer Drug, BAY 1895344, to the Usual Chemotherapy Treatment (Cisplatin, or Cisplatin and Gemcitabine) for Advanced Solid Tumors With Emphasis on Urothelial Cancer

Who this might be right for
Advanced Bile Duct CarcinomaAdvanced Breast CarcinomaAdvanced Cervical Carcinoma+31 more
National Cancer Institute (NCI) 74
Early research (Phase 1)Study completedNCT00004074
What this trial is testing

Interleukin-12 and Trastuzumab in Treating Patients With Cancer That Has High Levels of HER2/Neu

Who this might be right for
Advanced Adult Primary Liver CancerAnaplastic Thyroid CancerBone Metastases+124 more
National Cancer Institute (NCI) 15
Testing effectiveness (Phase 2)Study completedNCT04072445
What this trial is testing

Trifluridine/Tipiracil and Irinotecan for the Treatment of Advanced Refractory Biliary Tract Cancer

Who this might be right for
Advanced Bile Duct CarcinomaAdvanced Gallbladder CarcinomaRefractory Bile Duct Carcinoma+15 more
Mayo Clinic 28
Not applicableStudy completedNCT04596865
What this trial is testing

Recurrence After Whipple's (RAW) Study

Who this might be right for
Pancreatic CancerAmpullary CancerBile Duct Cancer+11 more
University Hospital Plymouth NHS Trust 1,484
Large-scale testing (Phase 3)Study completedNCT00538850
What this trial is testing

Fentanyl Sublingual Spray in Treating Patients With Breakthrough Cancer Pain

Who this might be right for
Cancer
INSYS Therapeutics Inc 130
Large-scale testing (Phase 3)Study completedNCT03768414
What this trial is testing

Gemcitabine Hydrochloride and Cisplatin With or Without Nab-Paclitaxel in Treating Patients With Newly Diagnosed Advanced Biliary Tract Cancers

Who this might be right for
Stage III Distal Bile Duct Cancer AJCC v8Stage III Gallbladder Cancer AJCC v8Stage III Intrahepatic Cholangiocarcinoma AJCC v8+14 more
SWOG Cancer Research Network 452
Early research (Phase 1)Study completedNCT00005842
What this trial is testing

Trastuzumab Plus R115777 in Treating Patients With Advanced or Metastatic Cancer

Who this might be right for
Cancer
National Cancer Institute (NCI) 24
Testing effectiveness (Phase 2)Study completedNCT01425879
What this trial is testing

MK2206 in Treating Patients With Advanced Refractory Biliary Cancer That Cannot Be Removed by Surgery

Who this might be right for
Advanced Adult Hepatocellular CarcinomaLocalized Non-Resectable Adult Liver CarcinomaRecurrent Adult Liver Carcinoma+5 more
National Cancer Institute (NCI) 8
Testing effectiveness (Phase 2)Active Not RecruitingNCT04941287
What this trial is testing

Testing A New Combination of Anti-cancer Immune Therapies, Atezolizumab and CDX-1127 (Varlilumab) With or Without the Addition of a Third Anti-cancer Drug, Cobimetinib, for Advanced-Stage Biliary Tract Cancer

Who this might be right for
Metastatic Distal Bile Duct AdenocarcinomaMetastatic Gallbladder CarcinomaMetastatic Intrahepatic Cholangiocarcinoma+7 more
National Cancer Institute (NCI) 57
Large-scale testing (Phase 3)Not Yet RecruitingNCT06923475
What this trial is testing

Neoadjuvant Gemcitabine and Cisplatin in Combination With Perioperative Pembrolizumab Versus Upfront Surgery for Patients With Primary Resectable and Borderline Resectable Perihilar and Distal Cholangiocarcinoma

Who this might be right for
Extrahepatic CholangiocarcinomaPerihilar CholangiocarcinomaDistal Cholangiocarcinoma+2 more
Amsterdam UMC, location VUmc 150
Not applicableUnknownNCT01522573
What this trial is testing

T-EUS for Gastrointestinal Disorders: A Multicenter Registry

Who this might be right for
CholangiocarcinomaPancreatic CancerBile Duct Cancer+11 more
Weill Medical College of Cornell University 1,000
Not applicableStudy completedNCT06671431
What this trial is testing

Role of Adjuvant Chemotherapy in Distal Cholangiocarcinoma

Who this might be right for
Distal CholangiocarcinomaAdjuvant Chemotherapy
Seoul National University Hospital 578
Testing effectiveness (Phase 2)Study completedNCT05239169
What this trial is testing

Immunotherapy With Durva and Treme With or Without Capecitabine in Adjuvant Treatment for Biliary Tract Cancer

Who this might be right for
Biliary Tract Cancer (CCA)Intrahepatic CholangiocarcinomaHilar Cholangiocarcinoma+2 more
Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest 40
Testing effectiveness (Phase 2)Active Not RecruitingNCT05564403
What this trial is testing

Study of Chemotherapy, With or Without Binimetinib in Advanced Biliary Tract Cancers in 2nd Line Setting (A ComboMATCH Treatment Trial)

Who this might be right for
Advanced Biliary Tract CarcinomaAdvanced Gallbladder CarcinomaAdvanced Intrahepatic Cholangiocarcinoma+14 more
National Cancer Institute (NCI) 66
Large-scale testing (Phase 3)Ended earlyNCT04163900
What this trial is testing

Comparing NUC-1031 Plus Cisplatin to Gemcitabine Plus Cisplatin in Patients With Advanced Biliary Tract Cancer

Who this might be right for
Biliary Tract Cancer
NuCana plc 773
Testing effectiveness (Phase 2)Active Not RecruitingNCT06717464
What this trial is testing

Toripalimab Combined With Capecitabine as Postoperative Adjuvant Therapy for Patients With Resectable Advanced Extrahepatic Biliary Tract Cancer

Who this might be right for
Gallbladder CancerHilar CholangiocarcinomaDistal Cholangiocarcinoma
Tianjin Medical University Cancer Institute and Hospital 110
Load More Results